Abstract
CHEK2-associated neoplasms account for a significant proportion of hereditary breast cancer (BC). The contribution of loss of heterozygosity (LOH) phenomenon to the pathogenesis of CHEK2-dependent tumors remains poorly understood, and almost all available data concern only one mutation type - CHEK2 1100delC.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have